Ibr, Bvd Cp Type1, Ncp Type 1 And 2, Pi3, Brsv, Killed Virus

Verify with FDA CVM →

12 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
12
Total Reports
8
Deaths Reported
6670.0%
Death Rate

Active Ingredients

Ibr, Bvd Cp Type1, Ncp Type 1 And 2, Pi3, Brsv, Killed Virus

Administration Routes

ParenteralUnknownSubcutaneous

Species Affected

Cattle 12

Most Affected Breeds

Aberdeen Angus 4
Cattle (unknown) 2
Crossbred Bovine/Cattle 2
Holstein-Friesian also known as Holstein 1
Mixed (Cattle) 1
Beefmaster 1
Red Angus 1

Most Reported Reactions

Death 8
Necropsy performed 3
Respiratory tract infection NOS 2
Respiratory signs 2
Lack of awareness 1
Injection site pain 1
Downer animal 1
Pneumonia 1
Lack of efficacy (bacteria NOS) 1
Lack of efficacy (endoparasite) - Trichostrongylus 1
Lack of efficacy - NOS 1
Foam in the mouth 1

Outcome Breakdown

Died
8 (57.1%)
Outcome Unknown
4 (28.6%)
Recovered/Normal
2 (14.3%)

Data Summary

Metric Value
Total adverse event reports 12
Reports involving death 8
Case-fatality rate (reported events) 6670.0%
Distinct species in reports 1
Distinct breeds in reports 7
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Ibr, Bvd Cp Type1, Ncp Type 1 And 2, Pi3, Brsv, Killed Virus Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 12 adverse event reports referencing Ibr, Bvd Cp Type1, Ncp Type 1 And 2, Pi3, Brsv, Killed Virus, including 8 reports in which the animal died — a 6670.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Ibr, Bvd Cp Type1, Ncp Type 1 And 2, Pi3, Brsv, Killed Virus. Reported administration routes include Parenteral, Unknown, Subcutaneous. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Ibr, Bvd Cp Type1, Ncp Type 1 And 2, Pi3, Brsv, Killed Virus reports are Cattle (12 reports), with Cattle accounting for the largest share. Within those species, Aberdeen Angus (4), Cattle (unknown) (2), Crossbred Bovine/Cattle (2) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Ibr, Bvd Cp Type1, Ncp Type 1 And 2, Pi3, Brsv, Killed Virus are Death (8), Necropsy performed (3), Respiratory tract infection NOS (2), Respiratory signs (2). Of the 14 reports with a coded outcome, Died is the leading category at 57.1%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Ibr, Bvd Cp Type1, Ncp Type 1 And 2, Pi3, Brsv, Killed Virus.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial